The role of counterions in the membrane-disruptive properties of pH-sensitive lysine-based surfactants

Acta Biomaterialia

Volumn 7, Issue 7, 2011, Pages 2846-2856

  Nogueira, D R ^a   Mitjans, M ^a   Infante, M R ^b   Vinardell, M P ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUTE OF ADVANCED CHEMISTRY OF CATALONIA IQAC CSIC   (Spain)

Author keywords

Cytotoxicity; Drug delivery; Hemolysis; Membrane disruption; pH sensitivity

Indexed keywords

AMINO ACIDS; ANIONIC SURFACTANTS; ASSAYS; BIOPHYSICS; CELL CULTURE; CELLS; CONTROLLED DRUG DELIVERY; CYTOTOXICITY; IONS; MEMBRANES; PH EFFECTS; PH SENSORS; SCANNING ELECTRON MICROSCOPY; TARGETED DRUG DELIVERY; TITRATION;

COUNTERIONS; DRUG-DELIVERY SYSTEMS; HAEMOLYSIS; HEMOLYTIC ACTIVITY; MEMBRANE DISRUPTION; PH SENSITIVE; PH-RESPONSIVE; PH-SENSITIVITY; PHYSIOLOGICAL PH; PROPERTY;

BLOOD;

COUNTERION; LYSINE; SURFACTANT;

ARTICLE; CELL MEMBRANE; CELL STRAIN 3T3; CELL STRUCTURE; CYTOTOXICITY; ENDOSOME; ERYTHROCYTE; HEMOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; PH; PH SENSITIVITY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY;

EID: 79957668944     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2011.03.017     Document Type: Article

References (57)

1. Plank C, Zauner W, Wagner E. Application of membrane-active peptides for drug and gene delivery across cellular membranes. Adv Drug Deliv Rev 1998;34:21-35. (Pubitemid 28464476)
2. Stayton PS, Hoffman AS, Murthy N, Lackey C, Cheung C, Tan P, et al. Molecular engineering of proteins and polymers for targeting and intracellular delivery of therapeutics. J Control Release 2000;65:203-20. (Pubitemid 30122926)
3. Temin HM. Safety considerations in somatic gene therapy of human disease with retrovirus vectors. Hum Gene Ther 1990;1:111-23. (Pubitemid 120034722)
4. Gordon EM, Anderson WF. Gene therapy using retroviral vectors. Curr Opin Biotechnol 1994;5:611-6.
5. McTaggart S, Al-Rubeai M. Retroviral vectors for human gene delivery. Biotechnol Adv 2002;20:1-31. (Pubitemid 34458446)
6. Plank C, Oberhauser B, Mechtler K, Koch C, Wagner E. The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J Biol Chem 1994;269:12918-24. (Pubitemid 24202092)
7. Kusonwiriyawong C, van de Wetering P, Hubbell JA, Merkle HP, Walter E. Evaluation of pH-dependent membrane-disruptive properties of poly(acrylic acid) derived polymers. Eur J Pharm Biopharm 2003;56:237-46. (Pubitemid 37072108)
8. Wang X-L, Ramusovic S, Nguyen T, Lu Z-R. Novel polymerizable surfactants with pH-sensitive amphiphilicity and cell membrane disruption for efficient siRNA delivery. Bioconjug Chem 2007;18:2169-77. (Pubitemid 350220022)
9. Wang XL, Nguyen T, Gillespie D, Jensen R, Lu ZR. A multifunctional and reversibly polymerizable carrier for efficient siRNA delivery. Biomaterials 2008;29:15-22. (Pubitemid 47599653)
10. Wang X-L, Xu R, Lu Z-R. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery. J Control Release 2009;134:207-13.
11. Morán MC, Infante MR, Miguel MG, Lindman B, Pons R. Novel biocompatible DNA gel particles. Langmuir 2010;26:10606-13.
12. Eccleston ME, Kuiper M, Gilchrist FM, Slater NKH. PH-responsive pseudopeptides for cell membrane disruption. J. Controlled Release 2000;69:297-307.
13. Kyriakides TR, Cheung CY, Murthy N, Bornstein P, Stayton PS, Hoffman AS. PH-sensitive polymers that enhance intracellular drug delivery in vivo. J Control Release 2002;78:295-303. (Pubitemid 34081874)
14. Al-Muallem HA, Wazeer MIM, Ali SA. Synthesis and solution properties of a new pH-responsive polymer containing amino acid residues. Polymer 2002;43:4285-95. (Pubitemid 34591912)
15. Yessine MA, Lafleur M, Meier C, Petereit HU, Leroux JC. Characterization of the membrane-destabilization properties of different pH-sensitive methacrylic acid copolymers. Biochim Biophys Acta 2003;1613:28-38. (Pubitemid 36776507)
16. Pack DW, Hoffman AS, Pun S, Stayton PS. Design and development of polymers for gene delivery. Nat Rev Drug Discov 2005;4:581-93. (Pubitemid 40975711)
17. Chen R, Yue Z, Eccleston ME, Williams S, Slater NKH. Modulation of cell membrane disruption by pH-responsive pseudo-peptides through grafting with hydrophilic side chains. J Control Release 2005;108:63-72. (Pubitemid 41476675)
18. Chen R, Khormaee S, Eccleston ME, Slater NKH. The role of hydrophobic amino acid grafts in the enhancement of membrane-disruptive activity of pH-responsive pseudo-peptides. Biomaterials 2009;30:1954-61.
19. Murthy N, Robichaud JR, Tirrell DA, Stayton PS, Hoffman AS. The design and synthesis of polymers for eukaryotic membrane disruption. J Control Release 1999;61:137-43. (Pubitemid 29406087)
20. Fisher D, Li YX, Ahlemeyer B, Krieglstein J, Kissel T. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials 2003;24:1121-31.
21. Moore NM, Sheppard CL, Barbour TR, Sakiyama-Elbert SE. The effect of endosomal escape peptides on in vitro gene delivery of polyethylene glycolbased vehicles. J Gene Med 2008;10:1134-49.
22. Trubetskoy VS, Wong SC, Subbotin V, Budker VG, Loomis A, Hagstrom JE, et al. Recharging cationic DNA complexes with highly charged polyanions for in vitro and in vivo gene delivery. Gene Ther 2003;10:261-71. (Pubitemid 36204415)
23. Christie RJ, Grainger DW. Design strategies to improve soluble macromolecular delivery constructs. Adv Drug Deliv Rev 2003;55:421-37. (Pubitemid 36293793)
24. Macián M, Seguer J, Infante MR, Selve C, Vinardell MP. Preliminary studies of the toxic effects of non-ionic surfactants derived from lysine. Toxicology 1996;106:1-9. (Pubitemid 26038268)
25. Sánchez L, Mitjans M, Infante MR, Vinardell MP. Assessment of the potential skin irritation of lysine-derivative anionic surfactants using mouse fibroblasts and human keratinocytes as an alternative to animal testing. Pharm Res 2004;21:1637-41. (Pubitemid 41184394)
26. Sánchez L, Mitjans M, Infante MR, Vinardell MP. Potential irritation of lysine derivative surfactants by hemolysis and HaCaT cell viability. Toxicol Lett 2006;161:53-60. (Pubitemid 41770876)
27. Sánchez L, Mitjans M, Infante MR, Vinardell MP. Determination of interleukin-1α in human NCTC 2544 keratinocyte cells as a predictor of skin irritation from lysine-based surfactants. Toxicol Lett 2006;167:40-6. (Pubitemid 44548276)
28. Sánchez L, Mitjans M, Infante MR, García MT, Manresa MA, Vinardell MP. The biological properties of lysine-derived surfactants. Amino Acids 2007;32:133-6. (Pubitemid 44866579)
29. Vives MA, Infante MR, Garcia E, Selve C, Maugras M, Vinardell MP. Erythrocyte hemolysis and shape changes induced by new lysine-derivative surfactants. Chem Biol Interact 1999;118:1-18. (Pubitemid 29112818)
30. Mosmann T. Rapid colorimetric assay to cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63. (Pubitemid 14203433)
31. Borenfreund E, Puerner JA. Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol Lett 1985;24:119-24. (Pubitemid 15103513)
32. Thomas JL, Barton SW, Tirrell DA. Membrane solubilisation by a hydrophobic polyelectrolyte: surface activity and membrane binding. Biophys J 1994;67:1101-6. (Pubitemid 24272959)
33. Mitjans M, Martínez V, Clapés P, Pérez L, Infante MR, Vinardell MP. Low potential ocular irritation of arginine-based gemini surfactants and their mixtures with nonionic and zwitterionic surfactants. Pharm Res 2003;20:1697-701. (Pubitemid 37268289)
34. Maher P, Singer SJ. Structural changes in membranes produced by the binding of small amphipathic molecules. Biochemistry 1984;23:232-40.
35. Jones MN. Surfactants in membrane solubilisation. Int J Pharm 1999;177:137-59. (Pubitemid 29073411)
36. Mellman I. Endocytosis and molecular sorting. Annu Rev Cell Dev Biol 1996;12:575-625. (Pubitemid 26422725)
37. Janshoff A, Bong DT, Steinem C, Johnson JE, Ghadiri MR. An animal virus-derived peptide switches membrane morphology: possible relevance to nodaviral transfection processes. Biochemistry 1999;38:5328-36.
38. Wasungu L, Hoekstra D. Cationic lipids, lipoplexes and intracellular delivery of genes. J Controlled Release 2006;116:255-64. (Pubitemid 44854274)
39. Maugras M, Infante MR, Gerardin Ch, Selve C, Vinardell MP. Possible effects of counterions on biological activities of anionic surfactants. Comp Biochem Physiol C 2001;128:541-5. (Pubitemid 32280845)
40. Pinazo A, Pérez L, Infante MR, Pons R. Unconventional vesicle-to-ribbon transition behaviour of diacyl glycerol amino acid based surfactants in extremely diluted systems induced by pH-concentration effects. Phys Chem Chem Phys 2004;6:1475-81.
41. Gedde MM, Huestis WH. Membrane potential and human erythrocyte shape. Biophys J 1997;72:1220-33. (Pubitemid 27113645)
42. Kleszczynska H, Sarapuk J. The role of counterions in the protective action of some antioxidants an the process of red cell oxidation. Biochem Mol Biol Int 1998;46:385-90. (Pubitemid 28499390)
43. Sarapuk J, Babrielska J, Przestalski S. Modification of model membrane by new bifunctional surfactants. Curr Topics Biophys 1997;21:54-7.
44. Sarapuk J, Kleszczynska H, Rozycka-Roszak B. The role of counterions in the interaction of bifunctional surface active compounds with model membranes. Biochem Mol Biol Int 1998;44:1105-10. (Pubitemid 28246142)
45. Epand RM, Bryszewska M. Modulation of the bilayer to hexagonal phase transition and solvation of phosphatidylethanolamines in aqueous salt solutions. Biochemistry 1988;27:8776-9.
46. Koynova RD, Tenchov BC, Quinn PJ. Sugars favor formation of hexagonal phase at the expense of the lamellar liquid-crystalline phase in hydrated phosphatidylethanolamines. Biochim Biophys Acta 1989;980:377-80. (Pubitemid 19225114)
47. Kleszczynska H, Bonarska D, Luczynski J, Witek S, Sarapuk J. Hemolysis of erythrocytes and erythrocyte membrane fluidity changes by new lysosomotropic compounds. J Fluorescence 2005;15:137-41. (Pubitemid 40661893)
48. Bielawski J. Two types of haemolytic activity of detergents. Biochim Biophys Acta 1990;1035:214-7. (Pubitemid 20251751)
49. Chernitsky E, Senkovich O. Mechanisms of anionic detergent-induced hemolysis. Gen Physiol Biophys 1998;17:265-70. (Pubitemid 128522885)
50. Sheetz MP, Singer SJ. Biological membranes as bilayer couples. A molecular mechanism of drug-erythrocyte interactions. Proc Natl Acad Sci USA 1974;71:4457-61.
51. Dubnicková M, Bobrowska-Hägerstrand M, Söderström T, Iglic A, Hägerstrand H. Gemini (dimeric) surfactant perturbation of the human erythrocyte. Acta Biochim Pol 2000;47:651-60.
52. Rasia M, Spengler MI, Palma S, Manzo R, Lo Nostro P, Allemandi. Effect of ascorbic acid based amphiphiles on human erythrocytes membrane. Clin Hemorheol Microcir 2007;36:133-40.
53. Manrique-Moreno M, Suwalsky M, Villena F, Garidel P. Effects of the nonsteroidal anti-inflammatory drug naproxen on human erythrocytes and on cell membrane molecular models. Biophys Chem 2010;147:53-8.
54. Martínez V, Sánchez L, Busquets MA, Infante MR, Vinardell MP, Mitjans M. Disturbance of erythrocyte lipid bilayer by amino acid-based surfactants. Amino Acids 2007;33:459-62. (Pubitemid 47347943)
55. Iglic A. A possible mechanism determining the stability of spiculated red blood cells. J Biomech 1997;30:35-40. (Pubitemid 26421554)
56. Wong P. Mechanism of control of erythrocyte shape: a possible relationship to band 3. J Theor Biol 1994;171:197-205. (Pubitemid 24371597)
57. Gedde MM, Yang E, Huestis WH. Shape response of human erythrocytes at altered cell pH. Blood 1995;86:1595-9.